Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery

A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the B...

Full description

Bibliographic Details
Published in:Journal of Advanced Research in Fluid Mechanics and Thermal Sciences
Main Author: Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R.
Format: Article
Language:English
Published: Semarak Ilmu Publishing 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85188927704&doi=10.37934%2farfmts.115.1.181192&partnerID=40&md5=e9ff1aea290a929d2daffb215750a6a5
id 2-s2.0-85188927704
spelling 2-s2.0-85188927704
Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R.
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
2024
Journal of Advanced Research in Fluid Mechanics and Thermal Sciences
115
1
10.37934/arfmts.115.1.181192
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85188927704&doi=10.37934%2farfmts.115.1.181192&partnerID=40&md5=e9ff1aea290a929d2daffb215750a6a5
A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the BET method, and possible interactions by FTIR analyses. Zerumbone released was done in both pH 1.2 and pH 7.4 mimicking the human gastrointestinal tract conditions for 24 hrs and subjected to kinetics study via suitable mathematical models to determine what governs the drug release with the results indicating that a sustained delivery of once-daily oral dosage form could be achieved. © 2024, Semarak Ilmu Publishing. All rights reserved.
Semarak Ilmu Publishing
22897879
English
Article
All Open Access; Hybrid Gold Open Access
author Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R.
spellingShingle Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R.
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
author_facet Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R.
author_sort Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R.
title Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
title_short Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
title_full Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
title_fullStr Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
title_full_unstemmed Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
title_sort Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
publishDate 2024
container_title Journal of Advanced Research in Fluid Mechanics and Thermal Sciences
container_volume 115
container_issue 1
doi_str_mv 10.37934/arfmts.115.1.181192
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85188927704&doi=10.37934%2farfmts.115.1.181192&partnerID=40&md5=e9ff1aea290a929d2daffb215750a6a5
description A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the BET method, and possible interactions by FTIR analyses. Zerumbone released was done in both pH 1.2 and pH 7.4 mimicking the human gastrointestinal tract conditions for 24 hrs and subjected to kinetics study via suitable mathematical models to determine what governs the drug release with the results indicating that a sustained delivery of once-daily oral dosage form could be achieved. © 2024, Semarak Ilmu Publishing. All rights reserved.
publisher Semarak Ilmu Publishing
issn 22897879
language English
format Article
accesstype All Open Access; Hybrid Gold Open Access
record_format scopus
collection Scopus
_version_ 1809677773454704640